Why Attend
Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate, with competition within industries high and the need to optimise performance greater than ever.
The global enzymes market size was valued at $9.9 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2020 to 2027.
With pharmaceutical, flavour & fragrance, consumer goods, animal feed, and agrochemical sectors all approaching the design, build and generation of new biocatalysts and molecules not found in nature, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering.
The 2nd Annual European Protein Engineering Congress, dedicated to uncovering the new and emerging practices, techniques and methods of protein and enzyme engineering across industries, will return 24th-25th November and 1st December 2020.
What’s new for 2020?
On 24th-25th November, we will once again deliver case studies from the industry along with content on directed evolution, novel API development, AI & machine learning, and computational approaches for enzyme discovery.
What’s happening 1st December?
This year’s Protein Engineering Congress will be delivered virtually. Therefore we will be making all content shown on 24th-25th November on-demand, allowing you time to dissolve and digest the content ready for the third day on 1st December, which will deliver in-depth discussions on industry challenges, dedicated time for networking and 1-2-1 meetings, exclusive roundtable discussion with industry leaders, and exciting partnership announcements from within the field.
Attend and you'll be able to; increase your product pipeline, increase product efficiency and increase differentiation by meeting the experts in the biocatalysis and protein engineering space.
This is not your average protein engineering congress...it's about industry, sharing knowledge and optimising your protein engineering method for the best outcomes.
The Virtual Experience
Top 10 benefits
- Tailor Your Agenda
- More Audience Participation
- Improved Audience Visibility
- On-Demand Content
- High Quality Speakers
- More Networking Opportunities
- Save Time & Money
- Increased Content
- More insights
- Business Development Opportunities - Talk to our team to find out out more [email protected].
Platform Preview
WHO WILL BE THERE
You can expect to meet:
Join us online to
Understand the requirements needed to achieve scale-up and industrial manufacture of chemical intermediates and engineered enzymes
Understand how enzyme engineering is being incorporated across multiple industry sectors to understand the greater market opportunity and commercial development
Hear case studies from within industry to guide your own internal R&D strategies and research projects
Hear how machine learning and AI is driving protein engineering innovation, allowing the improvement and optimisation of biocatalysts for industrial applications
Learn how the evolution of enzymes can allow the synthesis of non-canonical amino-acids to build new pharmaceutical drugs
Understand how engineered enzymes can yield enantiopure molecules through stereoselective synthesis, unachievable by other small molecule catalysts
2020 Speakers
Murray Brown
Keith Mulholland
Keith was born in and grew up in Liverpool. He obtained his first degree in 1985 at the University of Manchester Institute of Science and Technology, followed by a PhD at the same institution working for Professor Dick Stoodley on C-Nucleoside Synthesis. A Post-Doctoral Fellowship at the University of Texas at Austin working for Professor Philip Magnus on Alkaloid synthesis followed.
He returned to the UK in 1990 to take up a position as a Medicinal Chemist at SmithKline Beecham Harlow working on Serotonin Antagonists for the treatment of Irritable Bowel Syndrome and Depression. In 1996 he moved to the Synthetic Chemistry Department and started work in the area of Process Development.
Following the merger of SmithKline Beecham and Glaxo-Wellcome in 2001, Keith moved to Process R&D AstraZeneca Macclesfield. In his time there he has held various roles. He was the Lead Chemist for the Olaparib project from 2006-2007 and the Catalysis Technology Leader from 2008 to 2011.
Since 2011 he has been the Associate Principal Scientist and Departmental Lead for Biocatalysis within Pharmaceutical Technology and Development.
Pierre Gilles
Mehdi D. Davari
Per-Olof Syrén
Prof. Dr. Reinhard Sterner
Nikolaos A. Katerelos
Iman Farasat
Uwe Bornscheuer
Adrienne Davenport
Adam Garske
John Tucker
Jeremy Steflik
Ryan Phelan
David Entwistle
Tom Moody
Poster Session
Looking to showcase your recent work to the protein engineering community?
Our dedicated poster session is the perfect way to get your research noticed. In order to present a poster at the forum, you need to be registered as a delegate. Please note that there are limited spaces available, this will be assigned on a first come first served basis (subject to checks and successful registration). At the virtual congress, your presentation will be displayed in a dedicated poster 'area'. The poster presentation will take place after the lunch break on day one.
Poster abstract submission deadline is on 6th November 2020. Abstracts received after this time may not be accepted to please submit you abstracts as soon as possible! Posters should be sized A0 (841mm x 1189mm) in portrait orientation.
For more information please contact [email protected]
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Download 2020 Agenda
We're excited to share the newly released agenda for our 2020 European Protein Engineering Congress, hosted virtually! Please complete your details to receive a copy of full programme to explore the type of topics that will be covered.
We are looking forward to meeting you online in November!
DOWNLOAD 2020 AGENDA
Headline Partner
GenScript
Website: https://www.genscript.com/
GenScript Biotech is the world leader in biotechnology reagent service industry. Established in 2002 in New Jersey, United States, the company was the first to commercialize gene synthesis and successfully establish fully integrated capabilities for custom peptide synthesis, protein expression and engineering, custom antibody development and engineering, animal model development, in vitro/in vivo pharmacology as well as a variety of catalogue products, industrial enzymes and microbial reagents.
Associate Partner
Nostrum Biodiscovery
Website: http://nostrumbiodiscovery.com/
Please visit our website for more information.Senior Event Partners
Protéus by Seqens
Website: https://proteus.seqens.com/
Please visit our website for more information.Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Early Bird rates end in
— —
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.